PR Newswire
TORONTO, Aug. 9, 2017
TORONTO, Aug. 9, 2017 /PRNewswire/ - GeneNews Limited
("GeneNews" or the "Company") (TSX:GEN) today announced that it will release its second quarter 2017 financial results before
market open on Tuesday, August 15, 2017.
GeneNews' Chairman and CEO, James Howard-Tripp, will host a conference call at 8:30 a.m. ET to review the financial results and discuss business developments in the period.
Second Quarter 2017 Results Conference Call Details:
|
Date:
|
August 15, 2017
|
|
|
|
Time:
|
8:30 a.m. ET
|
|
|
|
Live Call:
|
1- 888-231-8191 (Canada and the United States)
|
|
1-647-427-7450 (International)
|
|
Conference ID:
|
68735471
|
|
|
|
Replay:
|
1-855-859-2056 (Canada and the United States)
|
|
1-416-849-0833 (International)
|
|
Password:
|
68735471
|
The call will also be broadcast live and archived on the Company's website at www.GeneNews.com in the Investor's section.
About GeneNews
GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized
medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Our mission is
to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with
personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease.
Our Richmond, Virginia-based Innovative Diagnostic Laboratory clinical reference lab specializes
in traditional and advanced clinical evidence-based blood testing that helps find, understand, and address cancer risk in patient
populations. Currently, IDL offers risk assessment blood tests for four prevalent cancer types - colon, lung, prostate and
breast. GeneNews' common shares trade on the Toronto Stock Exchange under the symbol 'GEN'. More information on GeneNews and IDL
can be found at www.GeneNews.com and www.myinnovativelab.com, respectively.
Forward-Looking Statements
This press release contains forward-looking statements identified by words such as "expects", "will" and similar
expressions, which reflect the Corporation's current expectations regarding future events. The forward-looking statements involve
risks and uncertainties that could cause the Corporation's actual events to differ materially from those projected herein.
Investors should consult the Corporation's ongoing quarterly filings and annual reports for additional information on risks and
uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking
statements. The Corporation disclaims any obligation to update these forward-looking statements, except as required by
law.
SOURCE GeneNews Limited
